Clinical Trial Update: LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating SBRT for inoperable centrally located non-small cell lung cancer (Stage I-II).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Stereotactic Body Radiotherapy (SBRT)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Non-small Cell Lung Cancer Stage I, Non-small Cell Lung Cancer Stage II | Phase 2 | Status: UNKNOWN